|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pavlidou E, Daponte A, Egea R, Dardiotis
E, Hadjigeorgiou GM, Barbadilla A and Agorastos T: Genetic
polymorphisms of FAS and EVER genes in a Greek population and their
susceptibility to cervical cancer: A case control study. BMC
Cancer. 16:9232016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schoell WM, Janicek MF and Mirhashemi R:
Epidemiology and biology of cervical cancer. Semin Surg Oncol.
16:203–211. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Boda D, Docea AO, Calina D, Ilie MA,
Caruntu C, Zurac S, Neagu M, Constantin C, Branisteanu DE,
Voiculescu V, et al: Human papilloma virus: Apprehending the link
with carcinogenesis and unveiling new research avenues (Review).
Int J Oncol. 52:637–655. 2018.PubMed/NCBI
|
|
6
|
Libra M, Scalisi A, Vella N, Clementi S,
Sorio R, Stivala F, Spandidos DA and Mazzarino C: Uterine cervical
carcinoma: Role of matrix metalloproteinases (Review). Int J Oncol.
34:897–903. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bosch FX, Lorincz A, Muñoz N, Meijer CJLM
and Shah KV: The causal relation between human papillomavirus and
cervical cancer. J Clin Pathol. 55:244–265. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Baritaki S, Sifakis S, Huerta-Yepez S,
Neonakis IK, Soufla G, Bonavida B and Spandidos DA: Overexpression
of VEGF and TGF-beta1 mRNA in Pap smears correlates with
progression of cervical intraepithelial neoplasia to cancer:
Implication of YY1 in cervical tumorigenesis and HPV infection. Int
J Oncol. 31:69–79. 2007.PubMed/NCBI
|
|
9
|
Castellsagué X and Muñoz N: Chapter 3:
Cofactors in human papillomavirus carcinogenesis - role of parity,
oral contraceptives, and tobacco smoking. J Natl Cancer Inst
Monogr. 2003:20–28. 2003. View Article : Google Scholar
|
|
10
|
Magnusson PK, Lichtenstein P and
Gyllensten UB: Heritability of cervical tumours. Int J Cancer.
88:698–701. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mammas IN, Zafiropoulos A and Spandidos
DA: Involvement of the ras genes in female genital tract cancer.
Int J Oncol. 26:1241–1255. 2005.PubMed/NCBI
|
|
12
|
Koffa M, Koumantakis E, Ergazaki M,
Malamoumitsi V and Spandidos D: Detection of ras gene-mutations and
hpv in lesions of the human female reproductive-tract. Int J Oncol.
5:189–195. 1994.PubMed/NCBI
|
|
13
|
Chen X, Jiang J, Shen H and Hu Z: Genetic
susceptibility of cervical cancer. J Biomed Res. 25:155–164. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang SS, Gonzalez P, Yu K, Porras C, Li Q,
Safaeian M, Rodriguez AC, Sherman ME, Bratti C, Schiffman M, et al:
Common genetic variants and risk for HPV persistence and
progression to cervical cancer. PLoS One. 5:e86672010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Harada H, Nagai H, Tsuneizumi M, Mikami I,
Sugano S and Emi M: Identification of DMC1, a novel gene in the TOC
region on 17q25.1 that shows loss of expression in multiple human
cancers. J Hum Genet. 46:90–95. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mol CD, Harris JM, McIntosh EM and Tainer
JA: Human dUTP pyrophosphatase: Uracil recognition by a beta
hairpin and active sites formed by three separate subunits.
Structure. 4:1077–1092. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ji W, Yang J, Wang D, Cao L, Tan W, Qian
H, Sun B, Qian Q, Yin Z, Wu M, et al: hSulf-1 gene exhibits
anticancer efficacy through negatively regulating VEGFR-2 signaling
in human cancers. PLoS One. 6:e232742011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu H, Fu X, Ji W, Liu K, Bao L, Yan Y, Wu
M, Yang J and Su C: Human sulfatase-1 inhibits the migration and
proliferation of SMMC-7721 hepatocellular carcinoma cells by
downregulating the growth factor signaling. Hepatol Res.
43:516–525. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Thamizhmani R and Vijayachari P:
Association of dengue virus infection susceptibility with
polymorphisms of 2′-5′-oligoadenylate synthetase genes: a
case-control study. Braz J Infect Dis. 18:548–550. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gervais V, Lamour V, Jawhari A, Frindel F,
Wasielewski E, Dubaele S, Egly JM, Thierry JC, Kieffer B and
Poterszman A: TFIIH contains a PH domain involved in DNA nucleotide
excision repair. Nat Struct Mol Biol. 11:616–622. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sun Y, Lu Y, Pen Q, Li T, Xie L, Deng Y
and Qin A: Interferon gamma +874 T/A polymorphism increases the
risk of cervical cancer: Evidence from a meta-analysis. Tumour
Biol. 36:4555–4564. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Orth G: Host defenses against human
papillomaviruses: Lessons from epidermodysplasia verruciformis.
Curr Top Microbiol Immunol. 321:59–83. 2008.PubMed/NCBI
|
|
23
|
Lazarczyk M, Dalard C, Hayder M, Dupre L,
Pignolet B, Majewski S, Vuillier F, Favre M and Liblau RS: EVER
proteins, key elements of the natural anti-human papillomavirus
barrier, are regulated upon T-cell activation. PLoS One.
7:e399952012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Castro FA, Ivansson EL, Schmitt M,
Juko-Pecirep I, Kjellberg L, Hildesheim A, Gyllensten UB and
Pawlita M: Contribution of TMC6 and TMC8 (EVER1 and EVER2) variants
to cervical cancer susceptibility. Int J Cancer. 130:349–355. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Contreras DN, Krammer PH, Potkul RK, Bu P,
Rossi JL, Kaufmann AM, Gissmann L and Qiao L: Cervical cancer cells
induce apoptosis of cytotoxic T lymphocytes. J Immunother.
23:67–74. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dybikowska A, Sliwinski W, Emerich J and
Podhajska AJ: Evaluation of Fas gene promoter polymorphism in
cervical cancer patients. Int J Mol Med. 14:475–478.
2004.PubMed/NCBI
|
|
27
|
Butler LM, Hewett PJ, Butler WJ and Cowled
PA: Down-regulation of Fas gene expression in colon cancer is not a
result of allelic loss or gene rearrangement. Br J Cancer.
77:1454–1459. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lee SH, Shin MS, Park WS, Kim SY, Dong SM,
Pi JH, Lee HK, Kim HS, Jang JJ, Kim CS, et al: Alterations of Fas
(APO-1/CD95) gene in transitional cell carcinomas of urinary
bladder. Cancer Res. 59:3068–3072. 1999.PubMed/NCBI
|
|
29
|
Shimonishi T, Isse K, Shibata F, Aburatani
I, Tsuneyama K, Sabit H, Harada K, Miyazaki K and Nakanuma Y:
Up-regulation of fas ligand at early stages and down-regulation of
Fas at progressed stages of intrahepatic cholangiocarcinoma reflect
evasion from immune surveillance. Hepatology. 32:761–769. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huang Q, Wang J and Hu Y: FAS-670 gene
polymorphism and cervical carcinogenesis risk: A meta-analysis.
Biomed Rep. 1:889–894. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Skol AD, Scott LJ, Abecasis GR and Boehnke
M: Joint analysis is more efficient than replication-based analysis
for two-stage genome-wide association studies. Nat Genet.
38:209–213. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Solé X, Guinó E, Valls J, Iniesta R and
Moreno V: SNPStats: A web tool for the analysis of association
studies. Bioinformatics. 22:1928–1929. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ziegler A, Van Steen K and Wellek S:
Investigating Hardy-Weinberg equilibrium in case-control or cohort
studies or meta-analysis. Breast Cancer Res Treat. 128:197–201.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Narita K, Staub J, Chien J, Meyer K, Bauer
M, Friedl A, Ramakrishnan S and Shridhar V: HSulf-1 inhibits
angiogenesis and tumorigenesis in vivo. Cancer Res. 66:6025–6032.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lai J, Chien J, Staub J, Avula R, Greene
EL, Matthews TA, Smith DI, Kaufmann SH, Roberts LR and Shridhar V:
Loss of HSulf-1 up-regulates heparin-binding growth factor
signaling in cancer. J Biol Chem. 278:23107–23117. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhou Q, Jiang Y, Yin W, Wang Y and Lu J:
Single-nucleotide polymorphism in microRNA-binding site of SULF1
target gene as a protective factor against the susceptibility to
breast cancer: A case-control study. Onco Targets Ther.
9:2749–2757. 2016.PubMed/NCBI
|
|
37
|
Okolicsanyi RK, Faure M, Jacinto JM,
Chacon-Cortes D, Chambers S, Youl PH, Haupt LM and Griffiths LR:
Association of the SNP rs2623047 in the HSPG modification enzyme
SULF1 with an Australian Caucasian breast cancer cohort. Gene.
547:50–54. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Han CH, Huang YJ, Lu KH, Liu Z, Mills GB,
Wei Q and Wang LE: Polymorphisms in the SULF1 gene are associated
with early age of onset and survival of ovarian cancer. J Exp Clin
Cancer Res. 30:52011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tamandani Kordi DM, Sobti RC and Shekari
M: Association of Fas-670 gene polymorphism with risk of cervical
cancer in North Indian population. Clin Exp Obstet Gynecol.
35:183–186. 2008.PubMed/NCBI
|
|
40
|
Ueda M, Terai Y, Kanda K, Kanemura M,
Takehara M, Yamaguchi H, Nishiyama K, Yasuda M and Ueki M: Fas gene
promoter −670 polymorphism in gynecological cancer. Int J Gynecol
Cancer. 16 Suppl 1:179–182. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Nunobiki O, Ueda M, Toji E, Yamamoto M,
Akashi K, Sato N, Izuma S, Torii K, Tanaka I, Okamoto Y, et al:
Genetic polymorphism of cancer susceptibility genes and HPV
infection in cervical carcinogenesis. Pathol Res Int.
2011:3640692011. View Article : Google Scholar
|
|
42
|
Lai HC, Lin WY, Lin YW, Chang CC, Yu MH,
Chen CC and Chu TY: Genetic polymorphisms of FAS and FASL
(CD95/CD95L) genes in cervical carcinogenesis: An analysis of
haplotype and gene-gene interaction. Gynecol Oncol. 99:113–118.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lai HC, Sytwu HK, Sun CA, Yu MH, Yu CP,
Liu HS, Chang CC and Chu TY: Single nucleotide polymorphism at Fas
promoter is associated with cervical carcinogenesis. Int J Cancer.
103:221–225. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Tan SC, Ismail MP, Duski DR, Othman NH and
Ankathil R: FAS c.-671A>G polymorphism and cervical cancer risk:
A case-control study and meta-analysis. Cancer Genet. 211:18–25.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hammond E, Khurana A, Shridhar V and
Dredge K: The role of heparanase and sulfatases in the modification
of heparan sulfate proteoglycans within the tumor microenvironment
and opportunities for novel cancer therapeutics. Front Oncol.
4:1952014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hur K, Han TS, Jung EJ, Yu J, Lee HJ, Kim
WH, Goel A and Yang HK: Up-regulated expression of sulfatases
(SULF1 and SULF2) as prognostic and metastasis predictive markers
in human gastric cancer. J Pathol. 228:88–98. 2012.PubMed/NCBI
|
